Three Mayo Clinic representatives have been nominated to serve on panels of the National Comprehensive Cancer Network (NCCN) Non-Hodgkin’s Lymphoma Guidelines Panels, which have split into three distinct panels. The Mayo Clinic representatives are:
- Thomas Habermann, Ph.D. (I ’82, HEM ’85), Division of Hematology/Oncology at Mayo Clinic in Rochester, professor of medicine: B-Cell Lymphomas Panel
Thomas Habermann, M.D.
- Stephen Ansell, M.D., Ph.D. (I ’96, HEMO ’99), Division of Hematology/Oncology at Mayo Clinic in Rochester, professor of medicine: panel vice chair, T-Cell/PCBC (Primary Cutaneous B-Cell) Lymphomas Panel
Stephen Ansell, M.D., Ph.D.
- Asher Chanan-Khan, M.D. (HEM ’14), chair of the Division of Hematology/Oncology at Mayo Clinic in Florida, professor of medicine: CLL (Chronic Lymphocytic Leukemia)/SLL (Small Lymphocytic Leukemia)/Hairy Cell Leukemia Panel
Asher Chanan-Khan, M.D.
